Hartland & Co »

Brainstorm Cell Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $346 1.5k 0.23
2024-06-30 $508 1.5k 0.34
2024-03-31 $822 1.5k 0.55

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Norfolk Southern (NSC)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Rus Mid Cap Etf (IWR)

View all positions for Hartland & Co

Top funds holding Brainstorm Cell Therapeutics

Geode Capital Management
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
Northern Trust
Raymond James & Associates
Jmac Enterprises
Wells Fargo & Company
Group One Trading
Tru Independence Asset Management 2
Citadel Advisors
Janney Montgomery Scott
Creative Planning
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics